Elsa Quintana

5.5k total citations · 2 hit papers
40 papers, 3.5k citations indexed

About

Elsa Quintana is a scholar working on Oncology, Immunology and Molecular Biology. According to data from OpenAlex, Elsa Quintana has authored 40 papers receiving a total of 3.5k indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Oncology, 12 papers in Immunology and 11 papers in Molecular Biology. Recurrent topics in Elsa Quintana's work include Nitric Oxide and Endothelin Effects (6 papers), Neuropeptides and Animal Physiology (6 papers) and Cancer Immunotherapy and Biomarkers (6 papers). Elsa Quintana is often cited by papers focused on Nitric Oxide and Endothelin Effects (6 papers), Neuropeptides and Animal Physiology (6 papers) and Cancer Immunotherapy and Biomarkers (6 papers). Elsa Quintana collaborates with scholars based in United States, Spain and Australia. Elsa Quintana's co-authors include Sean J. Morrison, Mark Shackleton, Timothy M. Johnson, Douglas R. Fullen, Michael S. Sabel, Eric R. Fearon, Hannah R. Foster, Gabriel Núñez, Nancy M. Joseph and Shenghui He and has published in prestigious journals such as Nature, Cell and Proceedings of the National Academy of Sciences.

In The Last Decade

Elsa Quintana

37 papers receiving 3.4k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Efficient tumour formation by single human melanoma cells

2008 1.3k citations Elsa Quintana, Mark Shackleton et al. Nature profile →
Heterogeneity in Cancer: Cancer Stem Cells versus Clonal Evolution

2009 871 citations Mark Shackleton, Elsa Quintana et al. Cell profile →

Peers

Countries citing papers authored by Elsa Quintana

Since Specialization

Citations

This map shows the geographic impact of Elsa Quintana's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Elsa Quintana with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Elsa Quintana more than expected).

Fields of papers citing papers by Elsa Quintana

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Elsa Quintana. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Elsa Quintana. The network helps show where Elsa Quintana may publish in the future.

Co-authorship network of co-authors of Elsa Quintana

This figure shows the co-authorship network connecting the top 25 collaborators of Elsa Quintana. A scholar is included among the top collaborators of Elsa Quintana based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Elsa Quintana. Elsa Quintana is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	RAS(ON) Multiselective Inhibition Drives Antitumor Immunity in Preclinical Models of NRAS-Mutant Melanoma 2025 ·Cancer Immunology Research ·Larissa Anastácio da Costa Carvalho, Nataliya Tovbis Shifrin, (unknown), Michael F. Emmons, Ximo Pechuan-Jorge, (unknown), Oscar E. Ospina, (unknown), Lillian Seu, (unknown), Aparna Hegde, Nikhil I. Khushalani, Elsa Quintana, Keiran S.M. Smalley	0
2	Abstract PR012: The RAS(ON) G12D-selective inhibitor RMC-9805 synergizes with anti-PD-1 to extend durability of antitumor activity in KRAS G12D-driven preclinical cancer models 2025 ·Cancer Immunology Research ·Marie Ménard, (unknown), Lilit Grigoryan, Jasmine Lee, Cheng Liu, (unknown), (unknown), (unknown), Ximo Pechuan-Jorge, (unknown), (unknown), (unknown), (unknown), Lillian Seu, (unknown), Elsa Quintana	1
3	T-cell Dependency of Tumor Regressions and Complete Responses with RAS(ON) Multi-selective Inhibition in Preclinical Models of Pancreatic Ductal Adenocarcinoma 2025 ·Cancer Discovery ·(unknown), William P. Vostrejs, Rina Sor, (unknown), Samantha B. Kemp, Il‐Kyu Kim, Adam B. Kramer, Nataliya Tovbis Shifrin, Nune Markosyan, Cynthia Clendenin, Mallika Singh, Elsa Quintana, Marie Ménard, Robert H. Vonderheide, Ben Z. Stanger	9
4	Abstract B024: RAS(ON) G12D- and Multi-selective inhibitor doublet drives complete responses in combination with anti-PD-1 in a preclinical model of MSS KRAS G12D mutant CRC 2025 ·Cancer Immunology Research ·(unknown), Cristina Blaj, (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), Miguel A. Sandoval, Jacqueline A.M. Smith, Elsa Quintana	1
5	Combining RAS(ON) G12C-selective inhibitor with SHP2 inhibition sensitises lung tumours to immune checkpoint blockade 2024 ·Nature Communications ·Panayiotis Anastasiou, Christopher Moore, Sareena Rana, (unknown), (unknown), (unknown), Jesse Boumelha, Edurne Mugarza, Sophie de Carné Trécesson, (unknown), Cristina Blaj, Robert Goldstone, Jacqueline A.M. Smith, Elsa Quintana, Míriam Molina‐Arcas, Julian Downward	5
6	Abstract LB015: Bi-steric mTORC1-selective inhibitors activate 4EBP1, suppress MYC, restore anti-tumor immunity, and cooperate with immune checkpoint inhibition to elicit tumor regression 2023 ·Cancer Research ·Wadie D. Mahauad‐Fernandez, Yu Chi Yang, Ian Lai, (unknown), (unknown), James Evans, (unknown), Xinyu Chen, (unknown), G. Leslie Burnett, Bianca J. Lee, Nuntana Dinglasan, Nataliya Tovbis Shifrin, (unknown), Elsa Quintana, Adrian L. Gill, Jacqueline A.M. Smith, Mallika Singh, Dean W. Felsher	1
7	Allosteric Inhibition of SHP2 Stimulates Antitumor Immunity by Transforming the Immunosuppressive Environment 2020 ·Cancer Research ·Elsa Quintana, Christopher J. Schulze, Darienne R. Myers, Tiffany J. Choy, Kasia Mordec, David Wildes, (unknown), (unknown), Elena S. Koltun, Adrian L. Gill, Mallika Singh, Stephen M. Kelsey, Mark A. Goldsmith, Robert J. Nichols, Jacqueline A.M. Smith	69
8	Shp1 Loss Enhances Macrophage Effector Function and Promotes Anti-Tumor Immunity 2020 ·Frontiers in Immunology ·Darienne R. Myers, Clare L. Abram, David Wildes, (unknown), (unknown), Christopher J. Schulze, Tiffany J. Choy, (unknown), (unknown), Yongmei Hu, Mallika Singh, (unknown), Mark A. Goldsmith, Elsa Quintana, Jacqueline A.M. Smith, Clifford A. Lowell	31
9	Synergistic effects of ion transporter and MAP kinase pathway inhibitors in melanoma 2016 ·Nature Communications ·Uğur Eskiocak, Vijayashree Ramesh, Jennifer G. Gill, Zhiyu Zhao, (unknown), Meng Wang, Travis Vandergriff, Mark Shackleton, Elsa Quintana, Arthur E. Frankel, Timothy M. Johnson, Ralph J. DeBerardinis, Sean J. Morrison	43
10	Merkel Cell Carcinoma Dependence on Bcl-2 Family Members for Survival 2014 ·Journal of Investigative Dermatology ·Monique Verhaegen, Doris Mangelberger, Jack W. Weick, (unknown), Paul W. Harms, Kevin T. Nash, Elsa Quintana, Paul Baciu, Timothy M. Johnson, Christopher K. Bichakjian, Andrzej A. Dlugosz	42
11	Enteric glia are multipotent in culture but primarily form glia in the adult rodent gut 2011 ·Journal of Clinical Investigation ·Nancy M. Joseph, Shenghui He, Elsa Quintana, (unknown), Gabriel Núñez, Sean J. Morrison	193
12	Phenotypic Heterogeneity among Tumorigenic Melanoma Cells from Patients that Is Reversible and Not Hierarchically Organized 2010 ·Cancer Cell ·Elsa Quintana, Mark Shackleton, Hannah R. Foster, Douglas R. Fullen, Michael S. Sabel, Timothy M. Johnson, Sean J. Morrison	446
13	Nitric oxide, derived from inducible nitric oxide synthase, decreases hypoxia inducible factor‐1α in macrophages during aspirin‐induced mesenteric inflammation 2010 ·British Journal of Pharmacology ·(unknown), Sara Calatayud, Carlos Hernández, Elsa Quintana, (unknown), (unknown), M D Barrachina	14
14	Heterogeneity in Cancer: Cancer Stem Cells versus Clonal Evolution breakdown → 2009 ·Cell ·Mark Shackleton, Elsa Quintana, Eric R. Fearon, Sean J. Morrison	871
15	Efficient tumour formation by single human melanoma cells breakdown → 2008 ·Nature ·Elsa Quintana, Mark Shackleton, Michael S. Sabel, Douglas R. Fullen, Timothy M. Johnson, Sean J. Morrison	1327
16	Nitrergic Modulation of Gastrointestinal Function During Early Endotoxemia 2006 ·Current Pharmaceutical Design ·Elsa Quintana, M D Barrachina, Juan V. Esplugues	0
17	Transcriptional up-regulation of nNOS in the dorsal vagal complex during low endotoxemia 2005 ·Life Sciences ·Elsa Quintana, Carlos Hernández, Anthony P. Moran, Juan V. Esplugues, M D Barrachina	5
18	Endotoxin stimulates fecal pellet output in rats through a neural mechanism 2003 ·Naunyn-Schmiedeberg s Archives of Pharmacology ·Sara Calatayud, M D Barrachina, Elsa Quintana, Sales Ibiza, Juan V. Esplugues	5
19	Endotoxin inhibits gastric emptying in rats via a capsaicin-sensitive afferent pathway 2001 ·Naunyn-Schmiedeberg s Archives of Pharmacology ·Sara Calatayud, M D Barrachina, (unknown), Elsa Quintana, Juan V. Esplugues	35
20	Physical-mechanical effects of Nd:YAG laser on the surface of sound dental enamel 1993 ·Biomaterials ·Francisco Márquez, Elsa Quintana, (unknown), Jesús Salgado	25

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact